Dysplastic histogenesis of cartilage growth plate by alteration of sulphation pathway: A transgenic mode

Connective Tissue Research

Volumn 50, Issue 4, 2009, Pages 232-242

  Cornaglia, Antonia Icaro ^a   Casasco, Andrea ^a   Casasco, Marco ^a   Riva, Federica ^a   Necchi, Vittorio ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Cartilage Histogenesis; Chondrodysplasia; Epiphyseal Growth Plate; Extracellular Matrix; Sulphate Transporter

Indexed keywords

COLLAGEN TYPE 10; PROTEOGLYCAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARTILAGE CELL; CELL DENSITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRUCTURE; CHONDRODYSPLASIA; CONTROLLED STUDY; EPIPHYSEAL CARTILAGE; EXTRACELLULAR MATRIX; GENE MUTATION; GROWTH PLATE; HISTOGENESIS; LONG BONE; MOUSE; NONHUMAN; SULFATION;

ANIMALS; ANION TRANSPORT PROTEINS; BIOLOGICAL TRANSPORT; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX; GROWTH PLATE; MICE; MICE, TRANSGENIC; MICROSCOPY, ELECTRON, TRANSMISSION; OSTEOCHONDRODYSPLASIAS; PROTEOGLYCANS; SULFATES;

ANIMALIA;

EID: 69349085583     PISSN: 03008207     EISSN: 16078438     Source Type: Journal    
DOI: 10.1080/03008200802684623     Document Type: Article

References (55)

1. Holtrop, M.E. (1972). The ultrastructure of the epiphyseal plate. II. The hypertrophic chondrocyte. Calcif. Tissue Res., 9, 140-151.
2. Fawcett, D.W. (1986). A textbook of Histology. (Saunders, Philadelphia).
3. Cancedda, R., Descalzi Cancedda, F., and Castagnola, P. (1995). Chondrocyte differentiation. Int. Rev. Cytol., 159, 265-358.
4. Vanky, P., Brockstedt, U., Hjerpe, A., and Wikstrom, B. (1998). Kinetic studies on epiphyseal growth cartilage in the normal mouse. Bone, 22, 331-339.
5. Iozzo, R.V. (1998).Matrix proteoglycans: Frommolecular design to cellular function. Annu. Rev. Biochem., 67, 609-652.
6. Heinegard, D., and Oldberg, A. (1989). Structure and biology of cartilage and bone matrix noncollagenous macromolecules. FASEB J., 3, 2042-2051.
7. Bianco, P., Fisher, L.W., Young, M.F., Termine, J.D., and Gehron Robey, P. (1990). Expression and localization of the two small proteoglycans biglycan and decorin in developing human skeletal and and non skeletal tissues. J. Histochem. Cytochem., 38, 1549-1568.
8. Spranger, J., Langer, L.O., and Wiedemann, H.R. (1974). Bone dysplasia. An Atlas of Constitutional Disorders of Skeletal Development (Gustav Fischer, Stuttgart).
9. Horton, W.A., Rimoin, D.L., Lachman, R.S., Skovby, F., Hollister, D.W., Spranger, J., Scott, C.I., and Hall, J.G. (1978). The phenotypic variability of diastrophic dysplasia. J. Pediatr., 93, 609-613.
10. Heinegard, D., and Oldberg, A. (1993). Glycosylated Matrix Proteins. In Connective Tissue and its Heritable Disorders-Molecular, Genetics and Medical Aspects. P.M. Royce and B. Steinmann (eds.) pp. 189-209. (Wiley-Liss, New York).
11. Sillence, D., Worthington, S., Dixon, J., Osborn, R., and Kozlowski, K. (1997). Atelosteogenesis syndromes: A review, with comments on their pathogenesis. Pediatr. Radiol., 27, 388-396.
12. Superti Furga, A. (2002). Skeletal dysplasias related to defects of sulfate metabolism. In Connective Tissue and its Heritable Disorders B. Steinman, and P. Royce (eds.), pp. 939-96. (Wiley-Liss, New York).
13. Hastbacka, J., de la Chapelle, A., Mahtani, M.M., Clines, G., Reeve-Daly, M.P., Daly, M., Hamilton, B.A., Kusumi, K., Trivedi, B., Weaver, A., Coloma, A., Lovett, M., Buckler, A., Kaitila, I., and Lander, S. (1994). The diastrophic dysplasia gene encodes a novel sulfate transporter: Positional cloning by fine-structure linkage disequilibrium mapping. Cell, 78, 1073-1087.
14. Hastbacka, J., Superti-Furga, A.,Wilcox,W.R., Rimoin, D.L., Cohn, D.H., and Lander, E.S. (1986). Atelosteogenesis type II is caused by mutations in the diastrophic dysplasia sulfate-transporter gene (DTDST): Evidence for a phenotypic series involving three chondrodysplasias. Am. J. Hum. Genet., 58, 255-262.
15. Rossi, A., Bonaventure, J., Delezoide, A.L., Cetta, G., and Superti-Furga, A. (1996). Undersulfation of proteoglycans synthesized by chondrocytes from a patient with achondrogenesis type 1B homozygous for an L483P substitution in the diastrophic dysplasia sulfate transporter. J. Biol. Chem., 271, 18456-18464.
16. Rossi, A., and Superti-Furga, A. (2001). Mutations in the diastrophic dysplasia sulfate transporter (DTDST) gene (SLC26A2): 22 novel mutations, mutation review, associated skeletal phenotypes, and diagnostic relevance. Hum. Mutat., 17, 159-171.
17. Superti-Furga, A., Hastbacka, J., Wilcox, W.R., Cohn, D.H., Van Der Harten, H.J., Rossi, A., Blau, N., Rimoin, D.L., Steinmann, B., Lander, E.S., andGitzelmann, R. (1996).Achondrogenesis type IB is caused bymutations in the diastrophic dysplasia sulphate transporter gene. Nat. Genet., 12, 100-102.
18. Forlino, A., Piazza, R., Tiveron, C., Della Torre, S., Tatangelo, L., Bonafe, L., Gualeni, B., Romano, A., Pecora, F., Superti-Furga, A., Cetta, G., and Rossi, A. (2005). A diastrophic dysplasia sulfate transporter (SLC26A2) mutant mouse: Morphological and biochemical characterization of the resulting chondrodysplasia phenotype. Hum. Mol. Genet., 14, 859-871.
19. Vanky, P., Brockstedt, U., Nurminen, M., Wikstrom, B., and Hjerpe, A. (2000). Growth parameters in the epiphyseal cartilage of brachymorphic (bm/bm) mice. Calcif. Tissue Int., 66, 355-362.
20. Barbieri, O., Astigiano, S., Morini,M., Tavella, S., Schito, A., Corsi, A., Di Martino, D., Bianco, P., Cancedda, R., and Garofalo, S. (2003). Depletion of cartilage collagen fibrils in mice carrying a dominant negative Col2a1 transgene affects chondrocyte differentiation. Am. J. Physiol. Cell Physiol., 285, 1504-1512.
21. Leighton, M.P., Nundall, S., Starborg, T., Meadows, R.S., Suleman, F., Knowles, L., Wagener, R., Thornton, D.J., Kadler, K.E., Boott-Handford, R.P., and Briggs, D. (2007). Decreased chondrocyte proliferation and dysregulated apoptosis in the cartilage growth plate are key features of a murine model of epiphyseal dysplasia caused by a matn3 mutation. Hum. Mol. Genet., 16, 1728-1741.
22. De Fazio, A., Leary, J.A., Hedley, D.W., and Tattersall, M.H.N. (1987). Immunohistochemical detection of proliferating cells in vivo. J. Histochem. Cytochem., 35, 571-577.
23. Casasco, A., Calligaro, A., and Casasco, M. (1992). Proliferative and functional stages of rat ameloblast differentiation as revealed by combined immunocytochemistry against enamel matrix proteins and bromodeoxyuridine. Cell Tissue Res., 270, 415-423.
24. Gabe, M. (1976). Histological Techniques. (Masson/Springer-Verlag, Paris).
25. Gonchoroff, N.J., Katzmann, J.A., Currie, R.M., Evans, E.L., Houck, D.W., Kline, B.C., Greipp, P.R., and Loken, M.R. (1986). S-phase detection with an antibody to bromodeoxyuridine. Role of Dnase pre-tretment. J. Immunol. Meth., 93, 97-101.
26. Mayne, R., Mayne, P., Ren, Z.X., Accavitti, M.A., Gurusiddappa, S., and Scott, P.G. (1994). Monoclonal antibody to the aminotelopeptide of type II collagen: Loss of the epitope after stromelysin digestion. Connect. Tissue Res., 31, 11-21.
27. Olsen, B.J., and Ninomiya, Y. (1993). "Basement Membrane Collages" In Guidebook to the Extracellular Matrix and Adhesion Proteins. Kreis and Vale (eds.) (Oxford University Press, Oxford, England).
28. Polak, J.M., and Van Noorden, S. (1986). Immunocytochemistry, Modern Methods and Applications. (John Wright and Sons, Bristol, England).
29. Kronenberg, H.M. (2003). Developmental regulation of the growth plate. Nature, 423, 332-336.
30. Provot, S., and Schipani, E. (2005).Molecular mechanisms of endochondral bone development. Biochem. Biophys. Res. Commun., 328, 658-665.
31. Satoh, H., Susaki, M., Shukunami, C., Iyama, K., Negoro, T., and Hiraki, Y. (1998). Functional analysis of diastrophic dysplasia sulfate transporter. Its involvement in growth regulation of chondrocytes mediated by sulfated proteoglycans. J. Biol. Chem., 273, 12307-12315.
32. Boskey, A.L., Maresca, M., Wikstrom, B., and Hjerpe, A. (1991). Hydroxyapatite formation in the presence of proteoglycans of reduced sulfate content: Studies in the brachymorphic mouse. Calcif. Tissue Int., 49, 389-393.
33. Hunziker, E.B., Schenk, R.K., and Cruz-Olive, L.M. (1987). Quantitation of chondrocyte performance in growth-plate cartilage during longitudinal bone growth. J. Bone Jt. Surg., 69, 162-173.
34. Scott, J.E. (1988). Proteoglycan-fibrillar collagen interactions. Biochem. J., 223, 587-597.
35. Vogel, K.G., Paulsson, M., and Heinegard, D. (1984). Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon. Biochem. J., 223, 587-597.
36. Leyh, T.S. (1993). The physical biochemistry and molecular genetics of sulfate activation. Crit. Rev. Biochem. Mol. Biol., 28, 515-542.
37. Habuchi, O. (2000). Diversity and functions of glycosaminoglycan sulfotransferases. Biochem. Biophys. Acta, 1474, 115-127.
38. Klaassen, C.D., and Boles, J.W. (1997). Sulfation and sulfotransferases 5: The importance of 3′-phosphoadenosine 5′-phsphosulfate (PAPS) in the regulation of sulfation. FASEB J., 11, 404-418.
39. Humphries, D.E., Silbert, C.K., and Silbert, J.E. (1988). Sulphation by cultured cells. Cysteine, cysteinesulphinic acid and sulphite as sources for proteoglycan sulphate. Biochem. J., 252, 305-308.
40. Folkman, J., and Moscona, A. (1978). Role of cell shape in growth control. Nature, 273, 345-349.
41. Ingber, D.E., Madri, J.A., and Jameson, J.D. (1986). Basementmembrane as a spatial organizer of polarized epithelia: Exogenous basement membrane reorients pancreatic epithelial tumor cells in vitro. Am. J. Pathol. 122, 129-139.
42. Ingber, D.E. (2003). Tensegrity II. How structural networks influence cellular information processing network. J. Cell Sci., 116, 1397-1408.
43. Chintala, S.K., Miller, R.R., and McDevitt, C.A. (1995). Role of heparan sulfate in the terminal differentiation of growth plate chondrocytes. Arch. Biochem. Biophys., 316, 227-234.
44. Hirsch, M.S., Lunsford, L.E., Trinkaus-Randall, V., and Svoboda, K.K.H. (1997). Chondrocyte survival and differentiation in situ are integrin mediated. Dev. Dynam., 221, 249-263.
45. Shimizu, M., Minakauchi, K., Kaji, S., and Koga, J. (1997). Condrocyte migration to fibronectin, type I collagen and type II collagen. Cell Struct. Funct., 22, 309-315.
46. Grashoff, C., Aszodi, A., Sakai, T., Hunziker, E.B., and Fassler, R. (2003). Integrin-linked kinase regulates chondrocyte shape and proliferation. EMBO Reports, 4, 432-438.
47. Habuchi, H., Suzuki, S., Saito, T., Tamura, T., Harada, T., Yoshida, K., and Kimata, K. (1992). Structure of a heparan sulphate oligosaccharide that binds to basic fibroblast growth factor. Biochem. J., 3, 805-813.
48. Salmivirta, M., Heino, J., and Jalkanen, M. (1992). Basic fibroblast growth factor-syndecan complex at cell surface or immobilized to matrix promotes cell growth. J. Biol. Chem., 267, 17606-17610.
49. Ishihara, M., Takano, R., Kanda, T., Hayashi, K., Hara, S., Kibuchi, H., and Yoshida, K. (1995). Importance of 6-O-sulfate groups of glucosamine residues in heparin for activation of FGF-1 and FGF-2. Biochem. J. 118, 1255-1260.
50. Adams, C.S., and Shapiro, I.M. (2002). The fate of terminally differentiated chondrocyte: Evidence for a microenvironmental regulation of chondrocyte apoptosis. Crit. Rev. Oral. Biol. Med., 13, 465-473.
51. Zenmyo, M., Setsuro, K., Kawabata, R., Sasaguri, Y., Inoue, A., and Morimatsu, M. (1996). Morphological and biochemical evidence for apoptosis in the terminal hypertrophic chondrocytes of the growth plate. J. Pathol., 180, 430-433.
52. Gibson, G. (1998). Active role of chondrocyte apoptosis in endochondral ossification. Microsc. Res. Tech., 43, 91-204.
53. Roach, H.I., Aigner, T., and Kouri, J.B. (2004). Chondroptosis: A variant of apoptotic cell death in chondrocytes? Apoptosis, 9, 265-277.
54. Ereinpreisa, J., and Roach, H.I. (1996). Epigenetic selection as a possible component of transdifferentiation. Further study of the commitment of hypertrophic chondrocytes to become osteocytes. Mech. Age Dev., 87, 165-182.
55. Bianco, P., Cancedda, F.D., Riminucci, M., and Cancedda, R. (1998). Bone formation via cartilage models: The "borderline" chondrocyte. Matrix Biol., 17, 185-192.